Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

krka d.d., novo mesto - rosuvastatin; amlodipine - film-coated tablet - 10 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz rosuvastatin and amlodipine

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

krka d.d., novo mesto - rosuvastatin; amlodipine - film-coated tablet - 10 mg/10 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz rosuvastatin and amlodipine

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - rosuvastatin calcium - oral tablet - 10mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - rosuvastatin calcium - oral tablet - 10mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - rosuvastatin calcium - oral tablet - 10mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - rosuvastatin calcium - oral tablet - 10mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - rosuvastatin calcium - oral tablet - 10mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - rosuvastatin calcium, quantity: 10.4 mg (equivalent: rosuvastatin, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; light magnesium oxide; crospovidone; titanium dioxide; hypromellose; triacetin; iron oxide red - primary hypercholesterolaemiapharmacor ezetimibe rosuvastatin composite pack is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,? not appropriately controlled with rosuvastatin or ezetimibe alone; or,? already treated with rosuvastatin and ezetimibe,homozygous familial hypercholesterolaemia (hofh),pharmacor ezetimibe rosuvastatin composite pack is indicated for patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).

Israeli - Kiingereza - Ministry of Health

astrazeneca (israel) ltd - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 10 mg - rosuvastatin - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Singapoo - Kiingereza - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - rosuvastatin calcium 10.4 mg eqv rosuvastatin - tablet, film coated - 10 mg - rosuvastatin calcium 10.4 mg eqv rosuvastatin 10 mg